Intervention

Fostamatinib

ClinicalTrials.gov intervention label

Clinical trials6
Recruiting0
Common conditions2
Lead sponsors shown1

Clinical trials

6 shown
Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With FostamatinibNCT01725230 · 2012-11-01
COMPLETED
A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid ArthritisNCT01640054 · 2012-07-01
TERMINATED
Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid ArthritisNCT01569074 · 2012-04-01
TERMINATED
Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy SubjectsNCT01355354 · 2011-06-01
COMPLETED
Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-StudyNCT02092961 · 2011-02-01
TERMINATED
Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)NCT01242514 · 2011-01-01
TERMINATED

Trial status mix

TERMINATED4
COMPLETED2

Phase mix

PHASE23
PHASE12
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.